JP6509238B2 - 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 - Google Patents

治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 Download PDF

Info

Publication number
JP6509238B2
JP6509238B2 JP2016548033A JP2016548033A JP6509238B2 JP 6509238 B2 JP6509238 B2 JP 6509238B2 JP 2016548033 A JP2016548033 A JP 2016548033A JP 2016548033 A JP2016548033 A JP 2016548033A JP 6509238 B2 JP6509238 B2 JP 6509238B2
Authority
JP
Japan
Prior art keywords
pyrimidin
pyrazolo
dimethyl
amine
dimethoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016548033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503830A (ja
JP2017503830A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
ウエストマン,ヤーコブ
Original Assignee
キュロヴィル・アクチボラグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キュロヴィル・アクチボラグ filed Critical キュロヴィル・アクチボラグ
Publication of JP2017503830A publication Critical patent/JP2017503830A/ja
Publication of JP2017503830A5 publication Critical patent/JP2017503830A5/ja
Application granted granted Critical
Publication of JP6509238B2 publication Critical patent/JP6509238B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016548033A 2014-01-22 2015-01-21 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体 Active JP6509238B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14152202 2014-01-22
EP14152202.9 2014-01-22
PCT/EP2015/051177 WO2015110491A2 (en) 2014-01-22 2015-01-21 Pyrazolo[1,5-a]pyrimidin-7-amine derivatives useful in therapy

Publications (3)

Publication Number Publication Date
JP2017503830A JP2017503830A (ja) 2017-02-02
JP2017503830A5 JP2017503830A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2018-02-22
JP6509238B2 true JP6509238B2 (ja) 2019-05-08

Family

ID=49989585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016548033A Active JP6509238B2 (ja) 2014-01-22 2015-01-21 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体

Country Status (11)

Country Link
US (1) US9963455B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP3096762B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP6509238B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN106061975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2015208205B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR112016016798B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2935658C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2954126T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2689788C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2015110491A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA201605666B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018248581B2 (en) * 2017-04-05 2022-05-26 Curovir Ab Heteroaromatic compounds useful in therapy
US11649238B2 (en) 2018-01-17 2023-05-16 Glaxosmithkline Intellectual Property Development Limited Substituted pyrazolo[1,5-a]pyrimidines as PI4K inhibitors
CN108727386A (zh) * 2018-07-16 2018-11-02 广州医科大学 一种吡唑并嘧啶类化合物及其制备方法和用途
MX2020013039A (es) 2018-08-21 2021-02-26 Kyorin Seiyaku Kk Derivado de anillo heteroaromatico biciclico.
IL281956B2 (en) * 2018-10-10 2024-07-01 Curovir Ab 2,6-DIMETHYL-N-((PYRIDlN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N- [(PYRIDlN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDlN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS
WO2020074160A1 (en) 2018-10-10 2020-04-16 Curovir Ab Condensed pyrimidine or pyridazine derivatives as antiviral agents
CN109988172B (zh) * 2019-01-10 2020-09-29 石家庄学院 一种吡唑并[1,5-a]嘧啶类杂环化合物及衍生物的合成方法
EP4028131B1 (en) 2019-08-20 2023-11-22 Curovir Ab Heteroaromatic compounds useful in therapy
WO2024184442A1 (en) 2023-03-09 2024-09-12 Curovir Ab Compound and formulation for systemic therapy by oral transmucosal administration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2585462B2 (ja) * 1989-10-25 1997-02-26 株式会社大塚製薬工場 ピラゾロ[1,5―a]ピリミジン誘導体
DE69130683T2 (de) * 1991-04-22 1999-05-06 Otsuka Pharmaceutical Factory, Inc., Naruto, Tokushima PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
CA2379585C (en) * 1999-09-30 2006-06-20 James W. Darrow Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
JP2005529919A (ja) * 2002-05-10 2005-10-06 スミスクライン ビーチャム コーポレーション 治療用化合物
US7601724B2 (en) * 2002-09-04 2009-10-13 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
JP4790265B2 (ja) * 2002-09-04 2011-10-12 シェーリング コーポレイション サイクリン依存性キナーゼインヒビターとしての新規ピラゾロピリミジン
GB0519957D0 (en) * 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
WO2010086040A1 (en) * 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
EP2539342B1 (en) * 2010-02-26 2015-04-15 Mitsubishi Tanabe Pharma Corporation Pyrazolopyrimidine compounds and their use as pde10 inhibitors
US8633198B1 (en) * 2011-09-20 2014-01-21 Nant Holdings Ip, Llc Small molecule inhibitors of influenza A RNA-dependent RNA polymerase

Also Published As

Publication number Publication date
WO2015110491A2 (en) 2015-07-30
US9963455B2 (en) 2018-05-08
JP2017503830A (ja) 2017-02-02
EP3096762A2 (en) 2016-11-30
WO2015110491A3 (en) 2015-09-17
RU2016134130A (ru) 2018-02-26
CA2935658A1 (en) 2015-07-30
CN106061975B (zh) 2019-09-24
RU2689788C2 (ru) 2019-05-29
RU2016134130A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2018-08-30
BR112016016798B1 (pt) 2022-06-28
BR112016016798A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2017-08-08
AU2015208205B2 (en) 2019-12-05
CN106061975A (zh) 2016-10-26
EP3096762B1 (en) 2023-06-28
NZ722290A (en) 2021-08-27
ES2954126T3 (es) 2023-11-20
ZA201605666B (en) 2021-01-27
US20160318937A1 (en) 2016-11-03
AU2015208205A1 (en) 2016-08-18
EP3096762C0 (en) 2023-06-28
CA2935658C (en) 2023-02-21

Similar Documents

Publication Publication Date Title
JP6509238B2 (ja) 治療に有用なピラゾロ[1,5−a]ピリミジン−7−アミン誘導体
RU2712196C2 (ru) Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии
KR101846136B1 (ko) Pde10 억제제 및 관련 조성물 및 방법
JP7200126B2 (ja) 療法において有用なヘテロ芳香族化合物
JP6401249B2 (ja) 2,3−ブタンジアミドエポキシド化合物ならびにその調製方法及び使用
JP2022504082A (ja) ウイルス感染を処置するための2,6-ジメチル-N-((ピリジン-4-イル)メチル)イミダゾ[1,2-b]ピリダジン-8-アミンおよび2,5-ジメチル-N-[(ピリジン-4-イル)メチル]ピラゾロ[1,5-a]ピリミジン-7-アミン誘導体
CN107141287B (zh) 2-亚胺-5-酮基-2,5-二氢-1-h-二吡啶并嘧啶类化合物
JP6071012B2 (ja) 4−アミノ−3−フェニルアミノ−6−フェニルピラゾロ[3,4−d]ピリミジン誘導体、その製造および抗ウイルス剤としての使用
NZ722290B2 (en) Pyrazolo[1,5-a]pyrimidin-7-amine derivatives useful in therapy
HK1254809B (en) Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy
HK1241362B (en) Compounds and methods for inducing browning of white adipose tissue

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180112

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190221

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190304

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190402

R150 Certificate of patent or registration of utility model

Ref document number: 6509238

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250